2024 Q1 Form 10-K Financial Statement

#000095017024022253 Filed on February 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $227.2M $228.6M $866.4M
YoY Change 10.89% 12.0% 10.73%
Cost Of Revenue $59.38M $55.94M $230.2M
YoY Change 3.93% -4.5% 7.61%
Gross Profit $167.9M $172.7M $636.2M
YoY Change 13.58% 18.64% 11.9%
Gross Profit Margin 73.87% 75.53% 73.43%
Selling, General & Admin $92.65M $90.15M $332.7M
YoY Change 22.88% 19.35% 15.78%
% of Gross Profit 55.19% 52.21% 52.3%
Research & Development $49.48M $45.22M $173.1M
YoY Change 20.69% 7.03% 10.29%
% of Gross Profit 29.47% 26.19% 27.21%
Depreciation & Amortization $33.95M $33.39M $135.3M
YoY Change -0.02% 2.45% 6.44%
% of Gross Profit 20.23% 19.34% 21.27%
Operating Expenses $160.1M $153.3M $660.1M
YoY Change 19.04% 12.86% 27.78%
Operating Profit $7.797M $19.36M -$23.93M
YoY Change -41.5% 99.72% -146.08%
Interest Expense $16.45M -$17.86M $63.58M
YoY Change 18.94% 41.44% 63.06%
% of Operating Profit 211.0% -92.22%
Other Income/Expense, Net $2.939M $31.56M $1.799M
YoY Change 5342.59% 1049.96% 157.37%
Pretax Income -$4.834M $33.06M -$84.55M
YoY Change -445.04% -17874.73% -269.56%
Income Tax -$4.200M $6.770M $5.524M
% Of Pretax Income 20.48%
Net Earnings -$597.0K $25.21M -$90.07M
YoY Change -127.34% 2251.77% -334.52%
Net Earnings / Revenue -0.26% 11.03% -10.4%
Basic Earnings Per Share $0.00 -$0.15
Diluted Earnings Per Share $0.00 $0.04 -$0.15
COMMON SHARES
Basic Shares Outstanding 604.7M 634.9M 617.9M
Diluted Shares Outstanding 598.3M 617.9M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $191.2M $195.6M $195.6M
YoY Change -43.49% -39.6% -39.6%
Cash & Equivalents $191.2M $195.6M $195.6M
Short-Term Investments
Other Short-Term Assets $31.29M $32.36M $50.26M
YoY Change -9.99% -10.99% -5.01%
Inventory
Prepaid Expenses
Receivables $102.0M $102.4M $102.4M
Other Receivables $0.00 $1.798M $1.798M
Total Short-Term Assets $343.2M $350.0M $350.0M
YoY Change -29.25% -26.94% -26.94%
LONG-TERM ASSETS
Property, Plant & Equipment $164.8M $160.4M $190.9M
YoY Change 9.52% 9.54% 6.44%
Goodwill $1.418B $1.418B
YoY Change -5.18% -5.18%
Intangibles $990.5M $1.015B
YoY Change -9.46% -9.28%
Long-Term Investments $10.23M $10.20M $10.23M
YoY Change 0.0% -0.27% 0.0%
Other Assets $43.70M $43.20M $67.17M
YoY Change -15.58% -5.91% -1.74%
Total Long-Term Assets $2.680B $2.701B $2.701B
YoY Change -6.16% -5.95% -5.95%
TOTAL ASSETS
Total Short-Term Assets $343.2M $350.0M $350.0M
Total Long-Term Assets $2.680B $2.701B $2.701B
Total Assets $3.024B $3.051B $3.051B
YoY Change -9.51% -8.95% -8.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.72M $16.32M $16.32M
YoY Change 50.16% -40.85% -40.85%
Accrued Expenses $39.50M $71.48M $78.27M
YoY Change -14.07% 0.05% 1.74%
Deferred Revenue $45.25M $43.57M
YoY Change 12.37% 23.63%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $8.000M $8.000M $11.06M
YoY Change 0.0% 0.0% 1.7%
Total Short-Term Liabilities $135.8M $152.9M $152.9M
YoY Change 8.87% 0.89% 0.89%
LONG-TERM LIABILITIES
Long-Term Debt $765.9M $767.5M $795.2M
YoY Change -0.85% -0.86% -1.2%
Other Long-Term Liabilities $7.347M $6.414M $104.8M
YoY Change 272.0% 141.31% 12.29%
Total Long-Term Liabilities $773.2M $773.9M $900.0M
YoY Change -0.16% -0.37% 0.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $135.8M $152.9M $152.9M
Total Long-Term Liabilities $773.2M $773.9M $900.0M
Total Liabilities $1.222B $1.252B $1.269B
YoY Change -2.42% -3.04% -2.82%
SHAREHOLDERS EQUITY
Retained Earnings -$1.127B -$1.126B
YoY Change 59.69% 59.12%
Common Stock $61.00K $60.00K
YoY Change -3.17% -3.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.784B $1.782B $1.782B
YoY Change
Total Liabilities & Shareholders Equity $3.024B $3.051B $3.051B
YoY Change -9.51% -8.95% -8.95%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$597.0K $25.21M -$90.07M
YoY Change -127.34% 2251.77% -334.52%
Depreciation, Depletion And Amortization $33.95M $33.39M $135.3M
YoY Change -0.02% 2.45% 6.44%
Cash From Operating Activities $55.24M $86.89M $250.0M
YoY Change 66.98% 6.66% 25.07%
INVESTING ACTIVITIES
Capital Expenditures $15.66M $11.84M $55.03M
YoY Change 7.77% 30.06% 14.77%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$15.66M -$11.84M -$55.03M
YoY Change 7.77% 30.06% -27.87%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net $328.5M
YoY Change
Debt Paid & Issued, Net $2.000M $8.000M
YoY Change 0.0% 0.0%
Cash From Financing Activities -43.85M -328.4M -323.0M
YoY Change 992.35% -11546.81% -1907.14%
NET CHANGE
Cash From Operating Activities 55.24M 86.89M 250.0M
Cash From Investing Activities -15.66M -11.84M -55.03M
Cash From Financing Activities -43.85M -328.4M -323.0M
Net Change In Cash -4.384M -253.4M -128.2M
YoY Change -130.1% -436.77% -190.78%
FREE CASH FLOW
Cash From Operating Activities $55.24M $86.89M $250.0M
Capital Expenditures $15.66M $11.84M $55.03M
Free Cash Flow $39.57M $75.05M $195.0M
YoY Change 113.4% 3.71% 28.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001818201
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 cccs Number Of Trading Days Used To Determine The Share Price
NumberOfTradingDaysUsedToDetermineTheSharePrice
P20D
CY2023 cccs Number Of Consecutive Trading Days Used To Determine The Share Price
NumberOfConsecutiveTradingDaysUsedToDetermineTheSharePrice
P30D
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-03551
CY2023 dei Entity Registrant Name
EntityRegistrantName
CCC Intelligent Solutions Holdings Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1546280
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
167 N. Green Street
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
9th Floor
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60607
CY2023 dei City Area Code
CityAreaCode
800
CY2023 dei Local Phone Number
LocalPhoneNumber
621-8070
CY2023 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2023 dei Trading Symbol
TradingSymbol
CCCS
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1847000000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
604651284
CY2023 dei Auditor Firm
AuditorFirmId
34
CY2023 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2023 dei Auditor Location
AuditorLocation
Chicago, IL
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
195572000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
323788000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5574000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5339000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102365000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
98353000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1798000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4015000
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
17900000
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
16556000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32364000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
36358000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
349999000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
479070000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
146443000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30456000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32874000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1015046000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1118819000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023Q4 us-gaap Goodwill
Goodwill
1417724000
CY2022Q4 us-gaap Goodwill
Goodwill
1495129000
CY2023Q4 cccs Deferred Financing Fees Revolver Net Non Current
DeferredFinancingFeesRevolverNetNonCurrent
1672000
CY2022Q4 cccs Deferred Financing Fees Revolver Net Non Current
DeferredFinancingFeesRevolverNetNonCurrent
2286000
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
22302000
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
20161000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10228000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10228000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
43197000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45911000
CY2023Q4 us-gaap Assets
Assets
3051040000
CY2022Q4 us-gaap Assets
Assets
3350921000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16324000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27599000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
71478000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
71445000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3689000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
922000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2023Q4 cccs Long Term Licensing Agreement Net Current
LongTermLicensingAgreementNetCurrent
3061000
CY2022Q4 cccs Long Term Licensing Agreement Net Current
LongTermLicensingAgreementNetCurrent
2876000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6788000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5484000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43567000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
35239000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
152907000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
151565000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
767504000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
774132000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
195365000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
241698000
CY2023Q4 cccs Long Term Licensing Agreement Net Non Current
LongTermLicensingAgreementNetNonCurrent
27692000
CY2022Q4 cccs Long Term Licensing Agreement Net Non Current
LongTermLicensingAgreementNetNonCurrent
30752000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50796000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54245000
CY2023Q4 cccs Warrant Liablity
WarrantLiablity
51501000
CY2022Q4 cccs Warrant Liablity
WarrantLiablity
36405000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6414000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2658000
CY2023Q4 us-gaap Liabilities
Liabilities
1252179000
CY2022Q4 us-gaap Liabilities
Liabilities
1291455000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
16584000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
603128781
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603128781
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
622072905
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
622072905
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
60000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
62000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2909757000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2754055000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1126467000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-707946000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1073000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-884000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1782277000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2045287000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3051040000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3350921000
CY2023 us-gaap Revenues
Revenues
866378000
CY2022 us-gaap Revenues
Revenues
782448000
CY2021 us-gaap Revenues
Revenues
688288000
CY2023 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
203324000
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
187001000
CY2021 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
169335000
CY2023 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
26464000
CY2022 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
26938000
CY2021 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
26320000
CY2023 cccs Impairment Of Acquired Technologies
ImpairmentOfAcquiredTechnologies
431000
CY2022 cccs Impairment Of Acquired Technologies
ImpairmentOfAcquiredTechnologies
0
CY2021 cccs Impairment Of Acquired Technologies
ImpairmentOfAcquiredTechnologies
0
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
230219000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
213939000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
195655000
CY2023 us-gaap Gross Profit
GrossProfit
636159000
CY2022 us-gaap Gross Profit
GrossProfit
568509000
CY2021 us-gaap Gross Profit
GrossProfit
492633000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
173106000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
156957000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5524000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11456000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26000000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
165991000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
140851000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
119594000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
148861000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
191844000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
167758000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
250098000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
71972000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72278000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72358000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
77405000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
4906000
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023 us-gaap Operating Expenses
OperatingExpenses
660084000
CY2022 us-gaap Operating Expenses
OperatingExpenses
516587000
CY2021 us-gaap Operating Expenses
OperatingExpenses
637308000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-23925000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
51922000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-144675000
CY2023 us-gaap Interest Expense
InterestExpense
63577000
CY2022 us-gaap Interest Expense
InterestExpense
38990000
CY2021 us-gaap Interest Expense
InterestExpense
58990000
CY2023 us-gaap Interest Income Operating
InterestIncomeOperating
16252000
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
908000
CY2021 us-gaap Interest Income Operating
InterestIncomeOperating
0
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15096000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-26073000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
64501000
CY2023 cccs Change In Fair Value Of Interest Rate Swap Agreements
ChangeInFairValueOfInterestRateSwapAgreements
0
CY2022 cccs Change In Fair Value Of Interest Rate Swap Agreements
ChangeInFairValueOfInterestRateSwapAgreements
0
CY2021 cccs Change In Fair Value Of Interest Rate Swap Agreements
ChangeInFairValueOfInterestRateSwapAgreements
8373000
CY2023 us-gaap Equity Method Investment Deferred Gain On Sale
EquityMethodInvestmentDeferredGainOnSale
0
CY2022 us-gaap Equity Method Investment Deferred Gain On Sale
EquityMethodInvestmentDeferredGainOnSale
3587000
CY2021 us-gaap Equity Method Investment Deferred Gain On Sale
EquityMethodInvestmentDeferredGainOnSale
0
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-15240000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1799000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6362000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
114000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84547000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49862000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-274919000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-90071000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
38406000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-248919000
CY2023 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2405000
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2021 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-92476000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
38406000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-248919000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617889384
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
607760886
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
543558222
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617889384
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
642841596
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
543558222
CY2023 us-gaap Profit Loss
ProfitLoss
-90071000
CY2022 us-gaap Profit Loss
ProfitLoss
38406000
CY2021 us-gaap Profit Loss
ProfitLoss
-248919000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-189000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-569000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-44000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-90260000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
37837000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-248963000
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2405000
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
0
CY2021 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
0
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-92665000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37837000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-248963000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1371615000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1007000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
254965000
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
704841000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
5180000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
60462000
CY2021 us-gaap Dividends
Dividends
269178000
CY2021 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
9006000
CY2021Q4 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
1395000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-44000
CY2021 us-gaap Profit Loss
ProfitLoss
-248919000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1872318000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
109387000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
27563000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3197000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-5015000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-569000
CY2022 us-gaap Profit Loss
ProfitLoss
38406000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2045287000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
144628000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
25434000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4761000
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-16715000
CY2023 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
328453000
CY2023 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2405000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-189000
CY2023 us-gaap Profit Loss
ProfitLoss
-90071000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1782277000
CY2023 us-gaap Profit Loss
ProfitLoss
-90071000
CY2022 us-gaap Profit Loss
ProfitLoss
38406000
CY2021 us-gaap Profit Loss
ProfitLoss
-248919000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36902000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27933000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
24451000
CY2023 cccs Amortization Of Intangible Asset
AmortizationOfIntangibleAsset
98436000
CY2022 cccs Amortization Of Intangible Asset
AmortizationOfIntangibleAsset
99216000
CY2021 cccs Amortization Of Intangible Asset
AmortizationOfIntangibleAsset
98678000
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
82742000
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-46333000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-34401000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-46883000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
144518000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
109497000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
261995000
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1753000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1878000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3682000
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
233000
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
257000
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
604000
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5743000
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
5663000
CY2021 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0
CY2023 cccs Gain Loss On Interest Rate Swap Agreement
GainLossOnInterestRateSwapAgreement
0
CY2022 cccs Gain Loss On Interest Rate Swap Agreement
GainLossOnInterestRateSwapAgreement
0
CY2021 cccs Gain Loss On Interest Rate Swap Agreement
GainLossOnInterestRateSwapAgreement
8373000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15096000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-26073000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
64501000
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
100000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-15240000
CY2023 cccs Noncash Lease Expense
NoncashLeaseExpense
1232000
CY2022 cccs Noncash Lease Expense
NoncashLeaseExpense
3697000
CY2021 cccs Noncash Lease Expense
NoncashLeaseExpense
6279000
CY2023 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0
CY2022 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
600000
CY2023 cccs Gain Loss On Cost Method Investment
GainLossOnCostMethodInvestment
0
CY2022 cccs Gain Loss On Cost Method Investment
GainLossOnCostMethodInvestment
3587000
CY2021 cccs Gain Loss On Cost Method Investment
GainLossOnCostMethodInvestment
0
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-79000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2651000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-620000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-104000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-541000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4001000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19844000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4725000
CY2023 cccs Increase Decrease In Deferred Costs Current
IncreaseDecreaseInDeferredCostsCurrent
1344000
CY2022 cccs Increase Decrease In Deferred Costs Current
IncreaseDecreaseInDeferredCostsCurrent
1487000
CY2021 cccs Increase Decrease In Deferred Costs Current
IncreaseDecreaseInDeferredCostsCurrent
3152000
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-4046000
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-9792000
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
12273000
CY2023 cccs Increase Decrease In Deferred Costs Non Current
IncreaseDecreaseInDeferredCostsNonCurrent
2141000
CY2022 cccs Increase Decrease In Deferred Costs Non Current
IncreaseDecreaseInDeferredCostsNonCurrent
-1956000
CY2021 cccs Increase Decrease In Deferred Costs Non Current
IncreaseDecreaseInDeferredCostsNonCurrent
7728000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3649000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
14501000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
7838000
CY2023 cccs Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-1186000
CY2022 cccs Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-3448000
CY2021 cccs Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-6354000
CY2023 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
4984000
CY2022 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-10018000
CY2021 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
3833000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11270000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15516000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1052000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1041000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4592000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8347000
CY2021 cccs Fair Value Of Assumed Public Warrants Exercised
FairValueOfAssumedPublicWarrantsExercised
60481000
CY2023 cccs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2145000
CY2022 cccs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-7241000
CY2021 cccs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-8398000
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8321000
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4196000
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4513000
CY2023 cccs Increase Decrease In Extinguishment Of Interest Rate Swap Liability
IncreaseDecreaseInExtinguishmentOfInterestRateSwapLiability
0
CY2022 cccs Increase Decrease In Extinguishment Of Interest Rate Swap Liability
IncreaseDecreaseInExtinguishmentOfInterestRateSwapLiability
0
CY2021 cccs Increase Decrease In Extinguishment Of Interest Rate Swap Liability
IncreaseDecreaseInExtinguishmentOfInterestRateSwapLiability
9987000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
4055000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-317000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-11755000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
250033000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
199907000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
127335000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55032000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47951000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38321000
CY2023 us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
0
CY2022 us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
3901000
CY2021 us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
0
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
32242000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2023 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
10228000
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
49000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55032000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76292000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48598000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25381000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
27693000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5085000
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4761000
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
3197000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8000000
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8000000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1336153000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16715000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5015000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
328453000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2023 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
789927000
CY2023 cccs Proceeds From Equity Infusion From The Business Combination
ProceedsFromEquityInfusionFromTheBusinessCombination
0
CY2022 cccs Proceeds From Equity Infusion From The Business Combination
ProceedsFromEquityInfusionFromTheBusinessCombination
0
CY2021 cccs Proceeds From Equity Infusion From The Business Combination
ProceedsFromEquityInfusionFromTheBusinessCombination
763300000
CY2023 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
CY2022 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
CY2021 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
4821000
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
0
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
0
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
269174000
CY2023 cccs Payments Of Deemed Distribution To Cccis Option Holders
PaymentsOfDeemedDistributionToCccisOptionHolders
0
CY2022 cccs Payments Of Deemed Distribution To Cccis Option Holders
PaymentsOfDeemedDistributionToCccisOptionHolders
0
CY2021 cccs Payments Of Deemed Distribution To Cccis Option Holders
PaymentsOfDeemedDistributionToCccisOptionHolders
9006000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1007000
CY2023 cccs Tax Effect Of Business Combination Transaction Costs
TaxEffectOfBusinessCombinationTransactionCosts
0
CY2022 cccs Tax Effect Of Business Combination Transaction Costs
TaxEffectOfBusinessCombinationTransactionCosts
0
CY2021 cccs Tax Effect Of Business Combination Transaction Costs
TaxEffectOfBusinessCombinationTransactionCosts
1395000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-323026000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17875000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-58440000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-191000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-246000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
129000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-128216000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
141244000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20426000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
323788000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
182544000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
162118000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195572000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
323788000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
182544000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2044000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
100000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8035000
CY2023 cccs Leasehold Improvements Acquired By Tenant Improvement Allowance
LeaseholdImprovementsAcquiredByTenantImprovementAllowance
0
CY2022 cccs Leasehold Improvements Acquired By Tenant Improvement Allowance
LeaseholdImprovementsAcquiredByTenantImprovementAllowance
0
CY2021 cccs Leasehold Improvements Acquired By Tenant Improvement Allowance
LeaseholdImprovementsAcquiredByTenantImprovementAllowance
16924000
CY2023 cccs Fair Value Of Assumed Public Warrants Exercised
FairValueOfAssumedPublicWarrantsExercised
0
CY2022 cccs Fair Value Of Assumed Public Warrants Exercised
FairValueOfAssumedPublicWarrantsExercised
0
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
200000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2023 us-gaap Paid In Kind Interest
PaidInKindInterest
61367000
CY2022 us-gaap Paid In Kind Interest
PaidInKindInterest
36636000
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
54980000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
42948000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
55697000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15233000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.933%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">—The preparation of the consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts, and the disclosures of contingent amounts in the Company’s consolidated financial statements and the accompanying notes. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Although the Company regularly assesses its estimates, actual results could differ from management’s estimates if past experience or other assumptions are not substantially accurate. Changes in estimates are recorded in the period in which they become known. Significant estimates in these consolidated financial statements include the estimation of contract transaction prices, the determination of the amortization period for contract assets, the valuation of goodwill and intangible assets, the estimates and assumptions associated with the valuation of the warrant liabilities, and the estimates and assumptions associated with stock incentive plans, including the fair value of common stock prior to the Business Combination.</span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:4.933%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Significant Customers and Concentration of Credit Risks</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">—The Company is potentially subject to concentration of credit risk primarily through its accounts receivable. The Company performs ongoing credit evaluations of its customers and maintains allowances for potential</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:4.933%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">credit losses which, when realized, have been within the range of management’s expectations. The Company generally does not require collateral. Credit risk on accounts receivables is minimized as a result of the large and diverse nature of the Company’s customer base.</span></p><p style="margin-left:4.933%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">During the years ended December 31, 2023, 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">, and 2021 no single customer represented more than </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">% of revenue.</span></p><p style="margin-left:4.933%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">, no customer had an account receivable greater than </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">% of accounts receivable. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">, one customer had an account receivable of </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">% of accounts receivable.</span></p>
CY2023 us-gaap Advertising Expense
AdvertisingExpense
1500000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1100000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1100000
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-left:4.933%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">—Certain reclassifications of prior period amounts have been made to conform to the current period presentation. For the year ended December 31, 2023, changes in the fair value of the Company's interest rate cap agreements are recognized within other income-net in the consolidated statements of operations and comprehensive (loss) income</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">. Corresponding amounts recognized during the year ended December 31, 2022, were previously classified as a change in fair value of derivative instruments and have been reclassified to conform to the current period presentation. The amounts reclassified had no impact on net (loss) income.</span></p>
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
900000
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
866378000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
782448000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
688288000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102365000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
98353000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78793000
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
17900000
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
16556000
CY2021Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
15069000
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
22302000
CY2022Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
20161000
CY2021Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
22117000
CY2023Q4 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
15198000
CY2022Q4 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
16437000
CY2021Q4 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
8622000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43567000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35239000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
31042000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1373000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1240000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1574000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36717000
CY2021Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
37186000
CY2020Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
26306000
CY2023 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-19197000
CY2022 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-17986000
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-15384000
CY2023 cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
22682000
CY2022 cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
17517000
CY2021 cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
26264000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
40202000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36717000
CY2021Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
37186000
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
17900000
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
16556000
CY2021Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
15069000
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
22302000
CY2022Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
20161000
CY2021Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
22117000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
40202000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36717000
CY2021Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
37186000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
36479000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
32616000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
28515000
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-434197000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-380977000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-334524000
CY2023 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
442658000
CY2022 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
384840000
CY2021 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
338625000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44940000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
36479000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
32616000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43567000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35239000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
31042000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1373000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1240000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1574000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44940000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
36479000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
32616000
CY2023 cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
35100000
CY2022 cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
31000000
CY2021 cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
26500000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1552000000
CY2023Q4 cccs Revenue Remaining Performance Obligation Revenue To Be Recognized Year One
RevenueRemainingPerformanceObligationRevenueToBeRecognizedYearOne
597000000
CY2023Q4 cccs Revenue Remaining Performance Obligation Revenue To Be Recognized Thereafter
RevenueRemainingPerformanceObligationRevenueToBeRecognizedThereafter
955000000
CY2022 cccs Discount Rate Based On Cost Of Debt
DiscountRateBasedOnCostOfDebt
0.10
CY2023 cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
CY2022 cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
100000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-80486000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
54799000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-261900000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-4061000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-4937000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-13019000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84547000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49862000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-274919000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
41804000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
37470000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
15263000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10053000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
8387000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5620000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
51857000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
45857000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20883000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-36253000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-26570000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-35284000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-10080000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-7831000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-11599000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-502000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
1054000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-2080000
CY2023 cccs Deferred Income Tax Expense Benefit Change In Valuation Allowance
DeferredIncomeTaxExpenseBenefitChangeInValuationAllowance
-502000
CY2022 cccs Deferred Income Tax Expense Benefit Change In Valuation Allowance
DeferredIncomeTaxExpenseBenefitChangeInValuationAllowance
1054000
CY2021 cccs Deferred Income Tax Expense Benefit Change In Valuation Allowance
DeferredIncomeTaxExpenseBenefitChangeInValuationAllowance
-2080000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-46333000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-34401000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-46883000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5524000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11456000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26000000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-17755000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
10471000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-57733000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
16255000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
-0.192
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0
CY2023 cccs Effective Income Tax Rate Reconciliation Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationExecutiveCompensationAmount
12555000
CY2023 cccs Effective Income Tax Rate Reconciliation Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationExecutiveCompensationPercent
-0.148
CY2022 cccs Effective Income Tax Rate Reconciliation Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationExecutiveCompensationAmount
12508000
CY2022 cccs Effective Income Tax Rate Reconciliation Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationExecutiveCompensationPercent
0.25
CY2021 cccs Effective Income Tax Rate Reconciliation Executive Compensation Amount
EffectiveIncomeTaxRateReconciliationExecutiveCompensationAmount
25362000
CY2021 cccs Effective Income Tax Rate Reconciliation Executive Compensation Percent
EffectiveIncomeTaxRateReconciliationExecutiveCompensationPercent
-0.092
CY2023 cccs Effective Income Tax Rate Reconciliation Fair Value Of Warrants Amount
EffectiveIncomeTaxRateReconciliationFairValueOfWarrantsAmount
3170000
CY2023 cccs Effective Income Tax Rate Reconciliation Fair Value Of Warrants Percent
EffectiveIncomeTaxRateReconciliationFairValueOfWarrantsPercent
-0.037
CY2022 cccs Effective Income Tax Rate Reconciliation Fair Value Of Warrants Amount
EffectiveIncomeTaxRateReconciliationFairValueOfWarrantsAmount
-5475000
CY2022 cccs Effective Income Tax Rate Reconciliation Fair Value Of Warrants Percent
EffectiveIncomeTaxRateReconciliationFairValueOfWarrantsPercent
-0.11
CY2021 cccs Effective Income Tax Rate Reconciliation Fair Value Of Warrants Amount
EffectiveIncomeTaxRateReconciliationFairValueOfWarrantsAmount
13545000
CY2021 cccs Effective Income Tax Rate Reconciliation Fair Value Of Warrants Percent
EffectiveIncomeTaxRateReconciliationFairValueOfWarrantsPercent
-0.049
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-3844000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.045
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-4074000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.081
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-3647000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.013
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
6920000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.082
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
3510000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.07
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
2914000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.011
CY2023 cccs Effective Income Tax Rate Reconciliation Impact Of Foreign Operations Amount
EffectiveIncomeTaxRateReconciliationImpactOfForeignOperationsAmount
1794000
CY2023 cccs Effective Income Tax Rate Reconciliation Impact Of Foreign Operations Percent
EffectiveIncomeTaxRateReconciliationImpactOfForeignOperationsPercent
-0.021
CY2022 cccs Effective Income Tax Rate Reconciliation Impact Of Foreign Operations Amount
EffectiveIncomeTaxRateReconciliationImpactOfForeignOperationsAmount
2807000
CY2022 cccs Effective Income Tax Rate Reconciliation Impact Of Foreign Operations Percent
EffectiveIncomeTaxRateReconciliationImpactOfForeignOperationsPercent
0.056
CY2021 cccs Effective Income Tax Rate Reconciliation Impact Of Foreign Operations Amount
EffectiveIncomeTaxRateReconciliationImpactOfForeignOperationsAmount
261000
CY2021 cccs Effective Income Tax Rate Reconciliation Impact Of Foreign Operations Percent
EffectiveIncomeTaxRateReconciliationImpactOfForeignOperationsPercent
-0.001
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
502000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.006
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1054000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.021
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2080000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.008
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-22000
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
439000
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.009
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-4723000
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.017
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
836000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.01
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
344000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.007
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
756000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.003
CY2023 cccs Income Tax Reconciliation Uncertain Tax Positions
IncomeTaxReconciliationUncertainTaxPositions
396000
CY2023 cccs Effective Income Tax Rate Reconciliation Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationUncertainTaxPositions
-0.005
CY2022 cccs Income Tax Reconciliation Uncertain Tax Positions
IncomeTaxReconciliationUncertainTaxPositions
-303000
CY2022 cccs Effective Income Tax Rate Reconciliation Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationUncertainTaxPositions
-0.006
CY2021 cccs Income Tax Reconciliation Uncertain Tax Positions
IncomeTaxReconciliationUncertainTaxPositions
594000
CY2021 cccs Effective Income Tax Rate Reconciliation Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationUncertainTaxPositions
-0.002
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-164000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.002
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-182000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.004
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-493000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.002
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-1279000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.015
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-515000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.01
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
912000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.003
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5524000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.065
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11456000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26000000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.095
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
43000000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
55700000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
15200000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
36329000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
37156000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
13751000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
14339000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
10373000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
10962000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
10875000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
10373000
CY2023Q4 cccs Deferred Tax Assets Capitalized R And E Net Of Amortization
DeferredTaxAssetsCapitalizedRAndENetOfAmortization
26082000
CY2022Q4 cccs Deferred Tax Assets Capitalized R And E Net Of Amortization
DeferredTaxAssetsCapitalizedRAndENetOfAmortization
10221000
CY2023Q4 cccs Deferred Tax Asset Sales Allowance And Doubtful Accounts
DeferredTaxAssetSalesAllowanceAndDoubtfulAccounts
1393000
CY2022Q4 cccs Deferred Tax Asset Sales Allowance And Doubtful Accounts
DeferredTaxAssetSalesAllowanceAndDoubtfulAccounts
1339000
CY2023Q4 cccs Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
0
CY2022Q4 cccs Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
673000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
479000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
506000
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
373000
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
386000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
775000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
826000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
100430000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
86781000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10875000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10373000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
89555000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
76408000
CY2023Q4 cccs Deferred Tax Liabilities Intangible Asset Amortization
DeferredTaxLiabilitiesIntangibleAssetAmortization
255572000
CY2022Q4 cccs Deferred Tax Liabilities Intangible Asset Amortization
DeferredTaxLiabilitiesIntangibleAssetAmortization
282032000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
11541000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
17628000
CY2023Q4 cccs Deferred Tax Liabilities Deferred Expense Deferred Contract Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredContractCosts
10044000
CY2022Q4 cccs Deferred Tax Liabilities Deferred Expense Deferred Contract Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredContractCosts
9235000
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
7078000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
7604000
CY2023Q4 cccs Deffered Income Tax Liability Interest Rate Cap
DefferedIncomeTaxLiabilityInterestRateCap
685000
CY2022Q4 cccs Deffered Income Tax Liability Interest Rate Cap
DefferedIncomeTaxLiabilityInterestRateCap
1607000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
284920000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
318106000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
195365000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
241698000
CY2023Q4 cccs Percentage Of Valuation Allowance Equal To Income Tax Benefit
PercentageOfValuationAllowanceEqualToIncomeTaxBenefit
1
CY2022Q4 cccs Percentage Of Valuation Allowance Equal To Income Tax Benefit
PercentageOfValuationAllowanceEqualToIncomeTaxBenefit
1
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
500000
CY2023 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
20-year
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3723000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3722000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1062000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
797000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
527000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
105000
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
897000
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
901000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4415000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3723000
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
107939000
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
103692000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5574000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5339000
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
102365000
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
98353000
CY2023Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
0
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
690000
CY2023Q4 us-gaap Other Assets
OtherAssets
10703000
CY2022Q4 us-gaap Other Assets
OtherAssets
11277000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32364000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36358000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5339000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3791000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4224000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
7079000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
4262000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
3634000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6844000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2714000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4067000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5574000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5339000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3791000
CY2023Q4 cccs Prepaid Saas Costs
PrepaidSaasCosts
7833000
CY2022Q4 cccs Prepaid Saas Costs
PrepaidSaasCosts
7423000
CY2023Q4 cccs Prepaid Service Fee
PrepaidServiceFee
5992000
CY2022Q4 cccs Prepaid Service Fee
PrepaidServiceFee
5268000
CY2023Q4 cccs Prepaid Software And Equipment Maintenance
PrepaidSoftwareAndEquipmentMaintenance
5547000
CY2022Q4 cccs Prepaid Software And Equipment Maintenance
PrepaidSoftwareAndEquipmentMaintenance
7638000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2289000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
4062000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
285418000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
245477000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
125002000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
99034000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
146443000
CY2023 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
36900000
CY2022 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
27900000
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
24500000
CY2022Q4 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
In December 2022, the Company terminated a corporate office lease which otherwise would have expired in March 2026.
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
5958000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
12390000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
16386000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
3497000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
2319000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
2110000
CY2023 us-gaap Lease Cost
LeaseCost
9455000
CY2022 us-gaap Lease Cost
LeaseCost
14709000
CY2021 us-gaap Lease Cost
LeaseCost
18496000
CY2022 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-3100000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y10M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y7M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y10M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.065
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.063
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
5706000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
11933000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
11403000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2825000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2876000
CY2022 cccs Lease Termination Fee
LeaseTerminationFee
3800000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7016000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7178000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7205000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5403000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6465000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
51027000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
84294000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
26710000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
57584000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
824576000
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
1520926000
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
103202000
CY2023Q4 us-gaap Goodwill
Goodwill
1417724000
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
1520926000
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
25797000
CY2022Q4 us-gaap Goodwill
Goodwill
1495129000
CY2021Q4 us-gaap Goodwill
Goodwill
1466884000
CY2022Q4 us-gaap Goodwill
Goodwill
1495129000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
77405000
CY2023Q4 us-gaap Goodwill
Goodwill
1417724000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1476470000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-651894000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
824576000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1666940000
CY2023Q4 cccs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
-651894000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1015046000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1487700000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-559351000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
928349000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1678170000
CY2022Q4 cccs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
-559351000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1118819000
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
80768000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
72454000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
72454000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
72454000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
72454000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
453992000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10200000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10200000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54593000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53530000
CY2023Q4 cccs Accrued Royalties And Licenses Current
AccruedRoyaltiesAndLicensesCurrent
4381000
CY2022Q4 cccs Accrued Royalties And Licenses Current
AccruedRoyaltiesAndLicensesCurrent
3832000
CY2023Q4 cccs Accrued Sales Tax Current
AccruedSalesTaxCurrent
2968000
CY2022Q4 cccs Accrued Sales Tax Current
AccruedSalesTaxCurrent
2615000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2572000
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2749000
CY2023Q4 cccs Software License Agreement Current
SoftwareLicenseAgreementCurrent
2233000
CY2022Q4 cccs Software License Agreement Current
SoftwareLicenseAgreementCurrent
3243000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2183000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1877000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2548000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3599000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
71478000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
71445000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
3937000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
0
CY2023Q4 cccs Software License Agreement Noncurrent
SoftwareLicenseAgreementNoncurrent
1004000
CY2022Q4 cccs Software License Agreement Noncurrent
SoftwareLicenseAgreementNoncurrent
1208000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1373000
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1240000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
100000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
100000
CY2023Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
0
CY2022Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
110000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6414000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2658000
CY2021Q3 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
525000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
767504000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
774132000
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
0
CY2021 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
0
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
16584000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
12363000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1926000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1878000
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
257000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
10485000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1669000
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1753000
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
233000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8732000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1436000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8000000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8000000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8000000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8000000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
752000000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
784000000
CY2020Q1 cccs Percentage Of Compound Interest Per Annum On The Preferred Share Issue Price
PercentageOfCompoundInterestPerAnnumOnThePreferredShareIssuePrice
0.10
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2405000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023 cccs Shares Authorized Total
SharesAuthorizedTotal
5000000000
CY2023 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603128781
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
603128781
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
622072905
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
622072905
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
65000000
CY2023Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
4875000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2023 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
2000000
CY2021Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
134600000
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
134500000
CY2023 cccs Decrease In Strike Price Per Option
DecreaseInStrikePricePerOption
66.4
CY2021 cccs Payments Of Deemed Distribution To Cccis Option Holders
PaymentsOfDeemedDistributionToCccisOptionHolders
9000000
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
126550986
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
140106862
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
(i) the extension of the performance period by one year, (ii) a change to the performance criteria, (iii) a change to the number of units to be issued depending on performance and (iv) for certain grants, imposing a maximum number of units to be issued depending on performance equal to 100% of the target. The modification to the performance-based RSUs subject to a market condition resulted in incremental stock-based compensation expense of $67.0 million, which will be recognized ratably over the modified performance periods. The amount of stock-based compensation expense related to the modified awards during the year ended December 31, 2023 was not significant.
CY2023 cccs Percentage Of Number Of Units To Be Issued Depending On Performance
PercentageOfNumberOfUnitsToBeIssuedDependingOnPerformance
1
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y9M18D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y2M12D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.28
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.32
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.35
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.35
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0436
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0487
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0228
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0051
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
55570039
CY2020Q4 cccs Share Based Compensation By Share Based Payment Award Non Vested Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationByShareBasedPaymentAwardNonVestedOptionsOutstandingWeightedAverageExercisePrice
3.03
CY2020 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingWeightedAverageRemainingContractualTerm
P6Y10M24D
CY2020Q4 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingAggregateIntrinsicValue
337358000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2822484
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.58
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1924063
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.7
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
823965
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.66
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
55644495
CY2021Q4 cccs Share Based Compensation By Share Based Payment Award Non Vested Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationByShareBasedPaymentAwardNonVestedOptionsOutstandingWeightedAverageExercisePrice
2.95
CY2021 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingWeightedAverageRemainingContractualTerm
P6Y
CY2021Q4 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingAggregateIntrinsicValue
469591000
CY2023 cccs Class Of Warrant Or Rights Date From Which Warrants Or Rights Exercisable Expired
ClassOfWarrantOrRightsDateFromWhichWarrantsOrRightsExercisableExpired
2026-07-30
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15100000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-26100000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
64500000
CY2023Q4 cccs Warrant Liablity
WarrantLiablity
51500000
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10081164
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.74
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
314071
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.46
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
45249260
CY2022Q4 cccs Share Based Compensation By Share Based Payment Award Non Vested Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationByShareBasedPaymentAwardNonVestedOptionsOutstandingWeightedAverageExercisePrice
2.99
CY2022 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingWeightedAverageRemainingContractualTerm
P4Y10M24D
CY2022Q4 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingAggregateIntrinsicValue
258470000
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8923718
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.85
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
537073
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.88
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
35788469
CY2023Q4 cccs Share Based Compensation By Share Based Payment Award Non Vested Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationByShareBasedPaymentAwardNonVestedOptionsOutstandingWeightedAverageExercisePrice
2.96
CY2023 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingWeightedAverageRemainingContractualTerm
P4Y
CY2023Q4 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingAggregateIntrinsicValue
301563000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
33971974
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.79
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
292059000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
35726785
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.96
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
301252000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
2900000
CY2023 cccs Share Based Compensation By Share Based Award Options Excercised Issued Shares Issued Net Of Tax Witholding Obligation
ShareBasedCompensationByShareBasedAwardOptionsExcercisedIssuedSharesIssuedNetOfTaxWitholdingObligation
8923718
CY2022 cccs Share Based Compensation By Share Based Award Options Excercised Issued Shares Issued Net Of Tax Witholding Obligation
ShareBasedCompensationByShareBasedAwardOptionsExcercisedIssuedSharesIssuedNetOfTaxWitholdingObligation
10074354
CY2021 cccs Share Based Compensation By Share Based Award Options Excercised Issued Shares Issued Net Of Tax Witholding Obligation
ShareBasedCompensationByShareBasedAwardOptionsExcercisedIssuedSharesIssuedNetOfTaxWitholdingObligation
1922019
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
96600000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y4M24D
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2023Q4 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2026-07-30
CY2021Q4 cccs Class Or Warrant Issued Price Per Share
ClassOrWarrantIssuedPricePerShare
0.1
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2023 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2021-08-29
CY2022Q4 cccs Warrant Liablity
WarrantLiablity
36400000
CY2023Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
18926000
CY2023Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
15590000
CY2023Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
12483000
CY2023Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
11451000
CY2023Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
9900000
CY2023Q4 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
29700000
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
98050000
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5743000
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
5663000
CY2021 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0
CY2023 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
6460000
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1082000
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
699000
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
114000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1799000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6362000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
114000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-90071000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
38406000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-248919000
CY2023 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2405000
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2021 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-92476000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
38406000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-248919000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617889384
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
607760886
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
543558222
CY2023 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2022 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
35080710000
CY2021 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617889384
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
642841596
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
543558222
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33700000
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8100000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32100000
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 us-gaap Revenues
Revenues
866378000
CY2022 us-gaap Revenues
Revenues
782448000
CY2021 us-gaap Revenues
Revenues
688288000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
146443000
CY2022Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
3900000
CY2023 cccs Cost Method Investments Recognized Gains
CostMethodInvestmentsRecognizedGains
3600000
CY2021Q4 cccs Cost Method Investments Carrying Value
CostMethodInvestmentsCarryingValue
300000

Files In Submission

Name View Source Status
0000950170-24-022253-index-headers.html Edgar Link pending
0000950170-24-022253-index.html Edgar Link pending
0000950170-24-022253.txt Edgar Link pending
0000950170-24-022253-xbrl.zip Edgar Link pending
cccs-20231231.htm Edgar Link pending
cccs-20231231.xsd Edgar Link pending
cccs-ex10_10.htm Edgar Link pending
cccs-ex10_11.htm Edgar Link pending
cccs-ex10_8.htm Edgar Link pending
cccs-ex10_9.htm Edgar Link pending
cccs-ex21_1.htm Edgar Link pending
cccs-ex23_1.htm Edgar Link pending
cccs-ex31_1.htm Edgar Link pending
cccs-ex31_2.htm Edgar Link pending
cccs-ex32_1.htm Edgar Link pending
cccs-ex32_2.htm Edgar Link pending
cccs-ex4_1.htm Edgar Link pending
cccs-ex97_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img87216667_0.jpg Edgar Link pending
img87216667_1.jpg Edgar Link pending
img87216667_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
cccs-20231231_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R125.htm Edgar Link pending
R126.htm Edgar Link pending
R127.htm Edgar Link pending
R128.htm Edgar Link pending
R129.htm Edgar Link pending
R13.htm Edgar Link pending
R130.htm Edgar Link pending
R131.htm Edgar Link pending
R132.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable